Anti-cancer drug discovery flawed, researchers claim
A team from Vanderbilt University (Nashville, TN, USA) has concluded that the current primary means of testing compounds for anti-cancer activity in cells is flawed, findings that may have far-reaching effects in the field of drug discovery.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.